Immunocompromised adults show weaker response to RSV vaccines

Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity -; primarily organ transplant recipients who take immunosuppressive medications to reduce the risk of rejection and others with immune system disorders -; do not respond as strongly to vaccines against the respiratory syncytial virus (RSV) as people in the same age group with normal immune function.